We are Johnson & Johnson Innovative Medicine
How collaboration supports future healthcare workersПодробнее
2023 U.S. Pricing Transparency Report: Creating the next era of healthcare advancements for patientsПодробнее
In Front of Cancer: Supporting Multiple Myeloma PatientsПодробнее
The Transforming Health Series: How R&D pushes the boundariesПодробнее
In Front of Cancer: Advancing Multiple Myeloma TreatmentПодробнее
The Transforming Health Series: When delivering medicine is time criticalПодробнее
The Transforming Health Series: Where market access meets patient accessПодробнее
In Front of Cancer: John’s StoryПодробнее
In Front of Cancer: Supporting Multiple Myeloma PatientsПодробнее
Profiles In STEM with Kanesha JonesПодробнее
In Front of Cancer: Charles’ StoryПодробнее
Lloyd Miller, J&J Innovative Medicine, On the Need for Diversity in Immunology Clinical TrialsПодробнее
Ambily Banerjee, J&J Innovative Medicine, on Why Representation in Clinical Trials MattersПодробнее
In Front of Cancer: Jaz’s StoryПодробнее
In Front of Cancer: Advancing Multiple Myeloma TreatmentПодробнее
IO and NICE Webinar: Facilitating UK market access for innovative medicinesПодробнее
Unlocking the Most Promising Science with External InnovatorsПодробнее
Leading where medicine is goingПодробнее
Johnson & Johnson Celebrates Earth Day 2024Подробнее
Johnson & Johnson Stock is at a 52 Week Low! (JNJ Stock Analysis!)Подробнее
